A Phase I/II Study of Bosutinib in Pediatric Patients with Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph+ Chronic Myeloid Leukemia, Study ITCC-054/COG AAML1921

Grant

Awarded By

Total Award Amount

  • 61880.00

    • Direct Costs

  • 45500.00

    • Sponsor Award Id

    • Contributor

  • Aman Wadhwa   Investigator  
  • Ana Xavier   Investigator  
  • Julie Wolfson-Stockman M.D.   Investigator  
  • Matthew Kutny M.D.   Principal Investigator